.jpg?#)
Dr. Reddy's Laboratories Price Target Cut By Citi Over Intensifying Generic Competition - Full Details
Citi notes that market expectations for Dr. Reddy's Semaglutide opportunity may be too optimistic.
Citi notes that market expectations for Dr. Reddy's Semaglutide opportunity may be too optimistic.
What's Your Reaction?
